Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02402764
Title Phase 2 Trial of Selinexor (KPT-330) for Metastatic TNBC
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

Her2-receptor negative breast cancer

Therapies

Selinexor

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field